After-Hours Stock Movers 02/28: (DDD) (ACI) (WDAY) Higher; (GDRX) (AMBA) (LCID) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Ambarella (AMBA) PT Lowered to $200 at Rosenblatt
March 1, 2022 7:20 AM ESTRosenblatt analyst Kevin Cassidy lowered the price target on Ambarella (NASDAQ: AMBA) to $200.00 (from $250.00) while maintaining a Buy rating.
The analyst commented, "Ambarella delivered an in-line quarter and a very slight miss to the April quarter estimates. Multiple supply chain issues that are... More
GoodRx Holdings Inc. (GDRX) PT Lowered to $30 at Goldman Sachs
March 1, 2022 6:58 AM ESTGoldman Sachs analyst Eric Sheridan lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $30.00 (from $43.00) while maintaining a Buy rating following results.
The analyst commented, "We reiterate our Buy rating but lower our PT from $43 to $30 to reflect both lowered operating... More
BigCommerce Holdings (BIGC) PT Lowered to $50 at Stifel
March 1, 2022 6:53 AM ESTStifel analyst J. Parker Lane lowered the price target on BigCommerce Holdings (NASDAQ: BIGC) to $50.00 (from $60.00) while maintaining a Buy rating.
The analyst commented, "BigCommerce closed out FY21 by beating expectations across all key revenue and supplemental metrics, including increased traction in mid-market and... More
Ambarella (AMBA) PT Lowered to $190 at Stifel
March 1, 2022 6:22 AM ESTStifel analyst Tore Svanberg lowered the price target on Ambarella (NASDAQ: AMBA) to $190.00 (from $230.00) while maintaining a Buy rating following results. The analyst cited:
Line Jan Q Revs, w/ +$0.04 non-GAAP (NG) EPS beat on higher NG GMs.... MoreGoodRx Holdings Inc. (GDRX) PT Lowered to $20 at JPMorgan
March 1, 2022 4:58 AM ESTJPMorgan analyst Doug Anmuth lowered the price target on GoodRx Holdings Inc. (NASDAQ: GDRX) to $20.00 (from $33.00) while maintaining a Underweight rating.
The analyst comments "GoodRx is focused on building the top consumer-focused digital healthcare platform in the US. Its core offering tracks... More
